ES383643A1 - Un procedimiento para resolver el racemato de dl - 5 - (3 -(tercibutilamino) - 2 - hidroxipropoxi) - 3, 4 - dihidro - 1(2h) - naftalenona en sus isomeros opticos. - Google Patents

Un procedimiento para resolver el racemato de dl - 5 - (3 -(tercibutilamino) - 2 - hidroxipropoxi) - 3, 4 - dihidro - 1(2h) - naftalenona en sus isomeros opticos.

Info

Publication number
ES383643A1
ES383643A1 ES70383643A ES383643A ES383643A1 ES 383643 A1 ES383643 A1 ES 383643A1 ES 70383643 A ES70383643 A ES 70383643A ES 383643 A ES383643 A ES 383643A ES 383643 A1 ES383643 A1 ES 383643A1
Authority
ES
Spain
Prior art keywords
salt
give
following optical
chloroform
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES70383643A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Pharmaceutical Co filed Critical Warner Lambert Pharmaceutical Co
Publication of ES383643A1 publication Critical patent/ES383643A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES70383643A 1969-09-17 1970-09-15 Un procedimiento para resolver el racemato de dl - 5 - (3 -(tercibutilamino) - 2 - hidroxipropoxi) - 3, 4 - dihidro - 1(2h) - naftalenona en sus isomeros opticos. Expired ES383643A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85924469A 1969-09-17 1969-09-17

Publications (1)

Publication Number Publication Date
ES383643A1 true ES383643A1 (es) 1976-06-01

Family

ID=25330421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES70383643A Expired ES383643A1 (es) 1969-09-17 1970-09-15 Un procedimiento para resolver el racemato de dl - 5 - (3 -(tercibutilamino) - 2 - hidroxipropoxi) - 3, 4 - dihidro - 1(2h) - naftalenona en sus isomeros opticos.

Country Status (13)

Country Link
US (1) US3649691A (es)
JP (1) JPS494218B1 (es)
BE (1) BE755071A (es)
BR (1) BR7022215D0 (es)
CH (1) CH540882A (es)
DE (1) DE2046043C3 (es)
DK (1) DK139356B (es)
ES (1) ES383643A1 (es)
FR (1) FR2068537B1 (es)
GB (1) GB1264775A (es)
NL (1) NL7013663A (es)
NO (1) NO135141C (es)
ZA (1) ZA704981B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
GB1464950A (en) * 1973-05-03 1977-02-16 Squibb & Sons Inc Naphthalene derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
CH621330A5 (es) * 1976-05-14 1981-01-30 Sandoz Ag
JPS5334024U (es) * 1976-08-31 1978-03-25
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
CA2526730A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
BRPI0714361A2 (pt) * 2006-07-14 2013-03-26 Ranbaxy Lab Ltd polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2974148A (en) * 1959-03-30 1961-03-07 Smith Kline French Lab Anorexigenic preparation and method of curbing the appetite
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines

Also Published As

Publication number Publication date
DK139356B (da) 1979-02-05
FR2068537A1 (es) 1971-08-27
ZA704981B (en) 1971-07-28
NL7013663A (es) 1971-03-19
DE2046043B2 (de) 1978-03-30
DK139356C (es) 1979-08-20
CH540882A (de) 1973-08-31
NO135141C (es) 1977-02-16
DE2046043C3 (de) 1978-12-14
BE755071A (fr) 1971-02-22
NO135141B (es) 1976-11-08
DE2046043A1 (de) 1971-03-25
JPS494218B1 (es) 1974-01-31
FR2068537B1 (es) 1974-02-01
BR7022215D0 (pt) 1973-04-26
US3649691A (en) 1972-03-14
GB1264775A (es) 1972-02-23

Similar Documents

Publication Publication Date Title
ES383643A1 (es) Un procedimiento para resolver el racemato de dl - 5 - (3 -(tercibutilamino) - 2 - hidroxipropoxi) - 3, 4 - dihidro - 1(2h) - naftalenona en sus isomeros opticos.
EP0052492B1 (en) 3-aryloxy-3-phenylpropylamines
Saari et al. Synthesis and biological activity of (6aS)-10, 11-dihydroxyaporphine, the optical antipode of apomorphine
EP0047536A2 (en) Substituted propylamines
US4029731A (en) Aminophenyltetralin compounds
GB1511463A (en) 1-acylamino methyl-1,2,3,4-tetrahydroisoquinolines
NO140497B (no) Fremgangsmaate for fremstilling av alfa-isomeren 2-klor-9-(3`-(n`-hydroksyetyl-piperazino-n)-propyliden)-tiaxanten, alifatiske karboksylsyreestere med 1-16 karbonatomer av denne og syreaddisjonssalter av disse forbindelser
GB1173227A (en) Amino-Isoquinolines
MacPhillamy et al. Rauwolfia Alkaloids. XVIII. 1 On the Constitution of Deserpidine and Reserpine
IL40220A (en) Anti-androgenic pharmaceutical compositions containing 2-(substituted methylene)cycloalkanones
US3344188A (en) d (-)-n-tert.butyl- and -n-isopropyl-1-phenyl-2-amino-ethanols
US4206234A (en) Triphenylbut-1-ene derivatives and pharmaceutical compositions and uses thereof
GB1575510A (en) Ester of an indole-derived aminoalcohol
US3781415A (en) Product,process and composition
US3004977A (en) Lower alkyl esters of 1-(2-benzoylethyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid and 1-(3-hydroxy-3-phenylpropyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid
PL100989B1 (pl) Sposob otrzymywania pochodnych kwasu l-alfa-hydrazyno-beta-fenylopropionowego
US3882164A (en) Dextrorotatory 3r-n-monomethyl-amino-4c-phenyl-4t-ethoxycarbonicyclohexene-1 and process for the production thereof
CA1050570A (en) Cyclopropylmethylamine derivatives
Bhakuni et al. Biosynthesis of the abnormal Erythrina alkaloids, cocculidine and cocculine
US3966770A (en) 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
US4098901A (en) Trifluoromethyl substituted compounds having antidepressive activity
ES8206435A1 (es) Procedimiento para la obtencion de un nuevo compuesto deri- vado del acido p-clorofenoxiacetico
US2907765A (en) Piperazine derivatives
GB1440380A (en) Pyrrolidine derivatives
GB1193521A (en) Novel Esters of 1-Phenyl-1-Benzyl-2-Methyl-3-Dimethylaminopropanol, the preparation thereof and Compositions containing the same